
|Videos|May 26, 2022
Dose Reductions and Treatment Breaks on Lenvatinib Therapy
Author(s)Tom Powles, MBBS, MRCP, MD, Brian Shimkus, MD
Dr Brian Shimkus describes how he doses lenvatinib for renal cell carcinoma treatment.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
All-Oral Revumenib Regimen May Show Advantage in Newly Diagnosed AML
2
Talquetamab Combo Yields Responses in Multiple Myeloma With True EMD
3
Linvoseltamab Yields High Response in Newly Diagnosed Multiple Myeloma
4
MARIPOSA Final OS Results in Asia Population Yield Meaningful Improvement in EGFR NSCLC
5




























































































